1990-2010: two decades of interferon-based therapy.

摘要: Twenty-five years have passed since interferon-α was first used in the treatment of chronic hepatitis C infection, and even now it remains an essential part standard care for this condition. At present, recommended is a combination pegylated interferon ribavirin A. There been enormous advances our understanding mechanisms through which works identifying factors related to response treatment. Even with development new protease inhibitors, likely that will remain component